Impact of adjuvant therapy on outcomes after curative‐intent resection for distal cholangiocarcinoma

The benefit of adjuvant therapy (AT) after curative resection of distal cholangiocarcinoma (DCC) remains unclear. The objective of the current study was to investigate the impact of AT on long‐term survival of patients who underwent curative‐intent resection for DCC.

[1]  E. Beal,et al.  Surgical Treatment of Distal Cholangiocarcinoma , 2022, Current oncology.

[2]  T. Pawlik,et al.  Trends in the use of adjuvant therapy for resected intrahepatic cholangiocarcinoma: getting ahead of the data. , 2021, Hepatobiliary surgery and nutrition.

[3]  F. Rocha,et al.  Early Recurrence Following Resection of Distal Cholangiocarcinoma: A New Tool for the Toolbox , 2021, Annals of Surgical Oncology.

[4]  I. Endo,et al.  Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma , 2021, Annals of Surgical Oncology.

[5]  E. Jensen,et al.  Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus? , 2020, Hepatobiliary surgery and nutrition.

[6]  I. Sato,et al.  Clinical anatomy of the anterior and posterior hepatic plexuses, including relations with the pancreatic plexus: A cadaver study , 2020, Clinical anatomy.

[7]  G. Gores,et al.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management , 2020, Nature Reviews Gastroenterology & Hepatology.

[8]  T. Shichinohe,et al.  Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas , 2020, Annals of Surgical Oncology.

[9]  D. Hanahan,et al.  Roadmap for the Emerging Field of Cancer Neuroscience , 2020, Cell.

[10]  Xiaonan Sun,et al.  Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  P. Frenette,et al.  Nerves in cancer , 2020, Nature Reviews Cancer.

[12]  J. Raftery,et al.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. , 2019, The Lancet. Oncology.

[13]  V. Cardinale.  Classifications and misclassification in cholangiocarcinoma , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[14]  K. Boudjema,et al.  Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Ando,et al.  Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer , 2018, The British journal of surgery.

[16]  S. Truant,et al.  Multicentre study of the impact of factors that may affect long-term survival following pancreaticoduodenectomy for distal cholangiocarcinoma. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[17]  M. Nagino,et al.  Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma , 2017, The British journal of surgery.

[18]  Yanming Zhou,et al.  Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. , 2017, Asian journal of surgery.

[19]  M. Nagino,et al.  Recurrence after resection with curative intent for distal cholangiocarcinoma , 2017, The British journal of surgery.

[20]  Jin‐Young Jang,et al.  Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution , 2016, Cancer research and treatment : official journal of Korean Cancer Association.

[21]  T. Pawlik,et al.  Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. , 2014, JAMA surgery.

[22]  Y. Murakami,et al.  Perineural Invasion in Extrahepatic Cholangiocarcinoma: Prognostic Impact and Treatment Strategies , 2013, Journal of Gastrointestinal Surgery.

[23]  J. Knox,et al.  Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Tae Hyun Kim,et al.  Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer. , 2011, International journal of radiation oncology, biology, physics.

[25]  S. Maithel,et al.  The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[26]  D. Cunningham,et al.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.

[27]  Y. Murakami,et al.  Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma , 2009, Annals of surgery.

[28]  J. Donohue,et al.  Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. , 2009, International journal of radiation oncology, biology, physics.

[29]  W. Hop,et al.  Adjuvant Intra-Arterial Chemotherapy and Radiotherapy Versus Surgery Alone in Resectable Pancreatic and Periampullary Cancer: A Prospective Randomized Controlled Trial , 2008, Annals of surgery.

[30]  M. Choti,et al.  Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database Analysis , 2007, Journal of Gastrointestinal Surgery.

[31]  Steven C Cunningham,et al.  Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.

[32]  T. Takada,et al.  Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial. , 1998, Hepato-gastroenterology.

[33]  K. Lillemoe,et al.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. , 1996, Annals of surgery.

[34]  OUP accepted manuscript , 2022, British Journal of Surgery.

[35]  Chengzhan Zhu,et al.  Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche. , 2019, American journal of cancer research.

[36]  S. Behrman,et al.  Distal cholangiocarcinoma. , 2014, The Surgical clinics of North America.